Health Canada Updates Canadians On Estimates Of Health Risks For Recalled Valsartan Drugs Containing Ndm

Valsartan Drug Recall Summary Health Canada is providing updated information about health risks associated with valsartan medications that contain the impurity NDMA (a substance that may increase cancer risk). The recalled valsartan drugs were distributed across Canada. This update reflects new safety findings related to these contaminated blood pressure medications.

Reason

New safety information

Category

consumer product recall

Country

Canada

Agency

HC-PRODUCTS

Recall date

2018-09-10

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/b17d7dc7-479f-452c-96ad-35855cd2c7e6